C
Christian Giro
Researcher at University of Düsseldorf
Publications - 4
Citations - 202
Christian Giro is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: Head and neck cancer & Cetuximab. The author has an hindex of 3, co-authored 4 publications receiving 194 citations.
Papers
More filters
Journal ArticleDOI
High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes
Christian Giro,Bernhard Berger,Edwin Bölke,I. Frank Ciernik,F. Duprez,Laura D. Locati,Sophie Maillard,Mahmut Ozsahin,Raphael Pfeffer,A. Gerry Robertson,Johannes A. Langendijk,Wilfried Budach +11 more
TL;DR: In this paper, a questionnaire was sent to all members of the EORTC Radiation Oncology Group and Head and Neck Group (111 institutions) to evaluate the widespread use of cetuximab and radiotherapy in HNC and to estimate the frequency of grades III and IV skin reactions in the radiation portals associated with this protocol.
Journal ArticleDOI
Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab.
Edwin Bölke,Peter Arne Gerber,Guido Lammering,Matthias Peiper,Anja Müller-Homey,H. Pape,Christian Giro,Christiane Matuschek,Daniela Bruch-Gerharz,Thomas K. Hoffmann,Stephan Gripp,Bernhard Homey,Wilfried Budach +12 more
TL;DR: It is indicated that cetuximab may have the potential to enhance the severity of radiation dermatitis in HNC patients and a systematic monitoring of cutaneous side effects during radiotherapy plus cetUXimab is advised in order to reliably estimate the frequency of severe Radiation dermatitis.
Journal ArticleDOI
Cystatin-C a sensitive diagnostic marker for evaluation of the renal function in patients with cisplatin based chemotherapy
Edwin Bölke,Christiane Matuschek,Matthias Peiper,Christian Giro,M. Pelzer,Wilfried Budach,Stephan Gripp +6 more
TL;DR: Cystatin C serum levels were evaluated in comparison to serum creatinine concentrations and plasma clearance of chromium 51-labeled EDTA (Cr-EDTA), in patients with advanced head and neck carcinoma receiving cisplatin-based chemotherapy to assess the validity of cyStatin C as an alternative endogenous marker of GFR.
Journal Article
Validity of S-100 B in patients after brain radiation.
Stephan Gripp,Matthias Peiper,Christiane Matuschek,Christian Giro,Gerald Steinbach,Derik Hermsen,van Griensven M,Wilfried Budach,Rainer Engers,Peter Arne Gerber,Hefter H,Spiess B,Klaus Orth,Edwin Bölke +13 more
TL;DR: Brain irradiation leads to a mild increase of S-100 B plasma levels, however, the absolute rise was far weaker compared to that seen in major brain injuries.